Lilly recruits Avidity Biosciences to develop antibody-oligonucleotide conjugates
Sunday, May 12, 2019 - 04:42
in Biology & Nature
Avidity's technology will help the duo get RNA therapies to immune cells
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via